Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.045
+0.235 (8.36%)
Jan 22, 2025, 1:04 PM EST - Market open
Anixa Biosciences Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | 2019 - 2015 |
| Revenue | - | - | 0.21 | - | 0.51 | - | Upgrade
|
| Cost of Revenue | - | - | 0.16 | - | 0.39 | - | Upgrade
|
| Gross Profit | - | - | 0.05 | - | 0.13 | - | Upgrade
|
| Selling, General & Admin | 7.44 | 7.44 | 6.29 | 7.17 | 7.07 | 5.93 | Upgrade
|
| Research & Development | 6.4 | 6.4 | 4.77 | 6.7 | 6.19 | 4.38 | Upgrade
|
| Operating Expenses | 13.83 | 13.83 | 11.06 | 13.88 | 13.26 | 10.32 | Upgrade
|
| Operating Income | -13.83 | -13.83 | -11.01 | -13.88 | -13.14 | -10.32 | Upgrade
|
| Interest & Investment Income | 1.13 | 1.13 | 1.08 | 0.1 | 0 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | -12.7 | -12.7 | -9.93 | -13.77 | -13.13 | -10.28 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.01 | -0.15 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.34 | Upgrade
|
| Pretax Income | -12.7 | -12.7 | -9.93 | -13.77 | -13.13 | -10.09 | Upgrade
|
| Earnings From Continuing Operations | -12.7 | -12.7 | -9.93 | -13.77 | -13.13 | -10.09 | Upgrade
|
| Minority Interest in Earnings | 0.14 | 0.14 | 0.12 | 0.18 | 0.17 | 0.07 | Upgrade
|
| Net Income | -12.55 | -12.55 | -9.81 | -13.6 | -12.95 | -10.02 | Upgrade
|
| Net Income to Common | -12.55 | -12.55 | -9.81 | -13.6 | -12.95 | -10.02 | Upgrade
|
| Shares Outstanding (Basic) | 32 | 32 | 31 | 30 | 29 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 32 | 31 | 30 | 29 | 22 | Upgrade
|
| Shares Change (YoY) | 2.96% | 2.96% | 2.00% | 6.28% | 28.57% | 12.33% | Upgrade
|
| EPS (Basic) | -0.39 | -0.39 | -0.32 | -0.45 | -0.45 | -0.45 | Upgrade
|
| EPS (Diluted) | -0.39 | -0.39 | -0.32 | -0.45 | -0.45 | -0.45 | Upgrade
|
| Free Cash Flow | -7.34 | -7.34 | -6.21 | -6.49 | -4.94 | -6.19 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.23 | -0.20 | -0.21 | -0.17 | -0.28 | Upgrade
|
| Gross Margin | - | - | 23.33% | - | 24.80% | - | Upgrade
|
| Operating Margin | - | - | -5243.33% | - | -2565.63% | - | Upgrade
|
| Profit Margin | - | - | -4671.90% | - | -2530.08% | - | Upgrade
|
| Free Cash Flow Margin | - | - | -2956.67% | - | -964.45% | - | Upgrade
|
| EBITDA | - | - | - | - | -13.1 | -10.28 | Upgrade
|
| D&A For EBITDA | - | - | - | - | 0.04 | 0.04 | Upgrade
|
| EBIT | -13.83 | -13.83 | -11.01 | -13.88 | -13.14 | -10.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.